Literature DB >> 8799685

Guidelines for the management of insulin-dependent diabetes mellitus in pregnancy.

J M Steel1, F D Johnstone.   

Abstract

The infant of an insulin-dependent diabetic mother is at increased risk of perinatal death, neonatal problems and major congenital malformations: Many of these problems are preventable. All young women with diabetes should receive contraceptive advice and information about pregnancy. The objects of pre-pregnancy care are to assess suit-ability for pregnancy, to optimise control in early pregnancy and to improve pregnancy outcome through the provision of individualised education and information. Pre-pregnancy care can reduce the congenital malformation rate to approximately that of the nondiabetic. In each area there should be one designated diabetologist and one designated obstetrician who, together with their team, should see all pregnant women in a combined clinic in a hospital with an intensive care baby unit. All pregnant women with diabetes should have 24-hour access to the specialist team. Tight glycaemic control during pregnancy can reduce complications of pregnancy greatly, improving infant mortality and morbidity. Insulin requirements usually change during pregnancy. Education about hypoglycaemia and avoidance of ketoacidosis is essential. Women should have regular examination of the fundi and renal function. They should have ultrasound scanning to assess gestation, to look for abnormalities and to assess fetal growth. Fetal monitoring should be used, particularly for those at high risk. Women with good diabetic control and no complications of diabetes or pregnancy may be delivered at 39 to 40 weeks but those at high risk earlier. During labour or caesarean section blood glucose should be normalised using intravenous glucose and insulin supervised by a specialist team. An experienced paediatrician should be available. Breast feeding should be encouraged.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8799685     DOI: 10.2165/00003495-199652010-00005

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  37 in total

1.  Pre-conception management of insulin-dependent diabetes: improvement of pregnancy outcome.

Authors:  B Rosenn; M Miodovnik; C A Combs; J Khoury; T A Siddiqi
Journal:  Obstet Gynecol       Date:  1991-06       Impact factor: 7.661

2.  Autonomic neuropathy in pregnancy.

Authors:  J M Steel
Journal:  Diabetes Care       Date:  1989-02       Impact factor: 19.112

3.  Elevated maternal hemoglobin A1c in early pregnancy and major congenital anomalies in infants of diabetic mothers.

Authors:  E Miller; J W Hare; J P Cloherty; P J Dunn; R E Gleason; J S Soeldner; J L Kitzmiller
Journal:  N Engl J Med       Date:  1981-05-28       Impact factor: 91.245

4.  The outcome of diabetic pregnancies in relation to the mother's blood sugar level.

Authors:  K Karlsson; I Kjellmer
Journal:  Am J Obstet Gynecol       Date:  1972-01-15       Impact factor: 8.661

5.  Insulin requirements during pregnancy in women with type I diabetes.

Authors:  J M Steel; F D Johnstone; R Hume; J H Mao
Journal:  Obstet Gynecol       Date:  1994-02       Impact factor: 7.661

6.  The California Diabetes and Pregnancy Programme: a statewide collaborative programme for the pre-conception and prenatal care of diabetic women.

Authors:  L Cousins
Journal:  Baillieres Clin Obstet Gynaecol       Date:  1991-06

7.  A randomized clinical trial of the insulin pump vs intensive conventional therapy in diabetic pregnancies.

Authors:  D R Coustan; E A Reece; R S Sherwin; M C Rudolf; S E Bates; S M Sockin; T Holford; W V Tamborlane
Journal:  JAMA       Date:  1986-02-07       Impact factor: 56.272

8.  Spontaneous abortion in patients with insulin-dependent diabetes mellitus: the effect of preconceptional diabetic control.

Authors:  D Dicker; D Feldberg; N Samuel; A Yeshaya; M Karp; J A Goldman
Journal:  Am J Obstet Gynecol       Date:  1988-05       Impact factor: 8.661

9.  Fetal plasma erythropoietin in pregnancies complicated by maternal diabetes mellitus.

Authors:  D R Salvesen; J M Brudenell; R J Snijders; R M Ireland; K H Nicolaides
Journal:  Am J Obstet Gynecol       Date:  1993-01       Impact factor: 8.661

10.  Preconception care of diabetes. Glycemic control prevents congenital anomalies.

Authors:  J L Kitzmiller; L A Gavin; G D Gin; L Jovanovic-Peterson; E K Main; W D Zigrang
Journal:  JAMA       Date:  1991-02-13       Impact factor: 56.272

View more
  1 in total

Review 1.  Maternal-fetal transport of hypoglycaemic drugs.

Authors:  Facundo Garcia-Bournissen; Denice S Feig; Gideon Koren
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.